GABAA Receptor Modulators as Emerging Therapeutic Agents for Depressive Disorders
Drug Design, Development and Therapy · 2026-06 · Volume 20 · 1-17
DOI: 10.2147/dddt.s608834 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-06. Verfasst von Bo-Yun Guan und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Second Norman Bethune of Jilin University, Changchun, Jilin, 130000, People's Republic of China. Hauptthemen laut MEDLINE: Receptors, GABA-A, Antidepressive Agents, Depressive Disorder. Die Arbeit nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Depression is a serious mental disorder that affects individuals across diverse demographic and socioeconomic groups. Its pathophysiology is multifactorial and incompletely understood, and currently available pharmacological treatments remain limited in efficacy and scope. This article examines the involvement of the gamma-aminobutyric acid (GABA)ergic system in the pathogenesis of depression and reviews the pharmacological effects, therapeutic efficacy, and recent research developments related to various GABA A receptor modulators in the treatment of depressive disorders, including benzodiazepines, intravenous anesthetics, and neurosteroids. These agents may exert antidepressant and anxiolytic effects through modulation and restoration of GABAergic neurotransmission. In addition, certain agents, such as etomidate and allopregnanolone, have been reported to enhance synaptic plasticity and attenuate neuroinflammatory processes, thereby contributing to the reduction of depressive symptoms through multiple neurobiological mechanisms. Keywords: BDNF, GABA A receptor modulators, GABA A Rs, neurosteroids
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Norman Bethune of Jilin University, Changchun, Jilin, 130000, People's Republic of China.
- Department of Obstetrics and Gynecology, The Second Norman Bethune of Jilin University, Changchun, Jilin, 130000, People's Republic of China.
Zitieren
APA
Guan, B. Y., & Li, Y. (2026). GABAA Receptor Modulators as Emerging Therapeutic Agents for Depressive Disorders. Drug Design, Development and Therapy, Volume 20, 1-17. https://doi.org/10.2147/dddt.s608834
Vancouver
Guan BY, Li Y. GABAA Receptor Modulators as Emerging Therapeutic Agents for Depressive Disorders. Drug Design, Development and Therapy. 2026;Volume 20:1-17. doi:10.2147/dddt.s608834
BibTeX
@article{Guan2026,
author = {Guan, Bo-Yun and Li, Yang},
title = {GABAA Receptor Modulators as Emerging Therapeutic Agents for Depressive Disorders},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--17},
doi = {10.2147/dddt.s608834}
}
EUVIMED